Impact of statins on short and long term mortality in severe community acquired pneumonia in the intensive care unit
8.0
来源：
Nature
关键字：
computational pathology
发布时间：
2025-11-21 23:38
摘要：
This study investigates the impact of statins on mortality in patients with severe community-acquired pneumonia (sCAP) in the ICU. Using real-world data from the MIMIC-IV database, it simulated a randomized controlled trial and found that statin therapy significantly reduced both acute and long-term mortality rates. The average treatment effect was −4.03%, with Kaplan-Meier analysis confirming improved survival for statin users. These findings suggest that statins could serve as a valuable co-adjuvant therapy in treating sCAP, warranting further research to optimize treatment protocols.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.5
technical_barrier_competition
0.0
关键证据
Statin therapy was associated with reduced mortality: average treatment effect − 4.03%.
Kaplan-Meier analysis showed significantly improved survival for statin users.
The study is the first to investigate statin use in severe community-acquired pneumonia.
真实性检查
否
AI评分总结
This study investigates the impact of statins on mortality in patients with severe community-acquired pneumonia (sCAP) in the ICU. Using real-world data from the MIMIC-IV database, it simulated a randomized controlled trial and found that statin therapy significantly reduced both acute and long-term mortality rates. The average treatment effect was −4.03%, with Kaplan-Meier analysis confirming improved survival for statin users. These findings suggest that statins could serve as a valuable co-adjuvant therapy in treating sCAP, warranting further research to optimize treatment protocols.